GlaxoSmithKline plc EV - Enterprise Value 2011-2026 | GSK

Annual EV - Enterprise Value GlaxoSmithKline plc

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
41.8 B	42.5 B	43.3 B	46.3 B	260 B	131 B	145 B	134 B	14.1 B	35.8 B	55.2 B	70.1 B	91.2 B	77.3 B	81 B

All numbers in GBP currency

Indicator range from annual reports

Maximum	Minimum	Average
260 B	14.1 B	84.6 B

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
BioNTech SE BNTX	-4.91 B	$ 95.5	-3.88 %	$ 27.2 B	Germany
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Midatech Pharma plc MTP	-1.76 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-4.92 M	-	-	$ 269 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	11.4 M	-	-	$ 231 M	USA
ACADIA Pharmaceuticals ACAD	3.33 B	$ 22.35	0.72 %	$ 3.7 B	USA
Galapagos NV GLPG	82.8 M	$ 28.39	-0.13 %	$ 2.69 B	Belgium
Grifols, S.A. GRFS	11.8 B	$ 8.27	0.49 %	$ 6.83 B	Spain
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 3.5	5.42 %	$ 5.76 M	Israel
Aeterna Zentaris AEZS	10.3 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
InflaRx N.V. IFRX	-2.36 M	$ 1.97	-7.51 %	$ 152 M	Germany
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	3.64 B	$ 23.42	-0.3 %	$ 2.98 B	USA
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	4.02 M	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	563 M	-	-	$ 8.42 M	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	38.2 M	-	17.91 %	$ 11.1 M	USA
Innate Pharma S.A. IPHA	259 M	$ 1.4	-2.1 %	$ 235 M	France
CRISPR Therapeutics AG CRSP	4.38 B	$ 52.38	-2.24 %	$ 4.71 B	Schweiz
Avenue Therapeutics ATXI	-1.76 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	629 M	$ 1.64	4.46 %	$ 436 M	Britain
Inventiva S.A. IVA	129 M	$ 5.42	2.85 %	$ 138 M	France
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Завод ДИОД DIOD	3.14 B	-	-	-	Russia
Фармсинтез LIFE	59.3 B	-	-	-	Russia
AstraZeneca PLC AZN	59.6 B	-	-	$ 96.9 B	Britain
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA